Egan Dwight H reported disposition to issuer involving 1,633 shares of Co-Diagnostics, Inc. at $5.07 for −$8.28k on May 23, 2026

Disposition to issuer
Form 4 code D. Disposition of issuer equity securities to the issuer under Rule 16b-3(e).
Chief Executive Officer
Chief Executive Officer
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$8,279.31Shares × reported price
Shares traded
1,633Common Stock
Price per share
$5.07Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
27,893Direct
Trade date
May 23, 2026Disposition to issuer
Filed
May 27, 2026, 4:04 PM ET4-day reporting delay
Accession
0001712187-26-000002Code D · Transaction 87306
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 23, 2026Option exercise4,584$0.00$0Trade 87308
May 23, 2026Grant4,584$0.00$0Trade 87304
3 transaction rows in this filing. Joint filers share the same rows.

CODX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CODX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −77%1w ago −82%1d ago −31%
Returns since7d −29%30d −58%90d −83%180d1y

Footnotes in full

F1: Included in 9,167 restricted stock units awarded to the Reporting Person on May 15, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2023. Included in 9,167 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2024. Included in 9,167 restricted stock units awarded to the Reporting Person on August 13, 2025, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2025. F2: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSU's. This sale is mandated by the Issuer's election, under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.